Alluvi Retatrutide 20mg Milan

Showing the single result

  • buy Alluvi Retatrutide 20mg New South Wales
    Specification Details
    Product Name Alluvi Retatrutide 20mg
    Active Ingredient Retatrutide (LY3437943)
    Concentration 20mg per vial
    Mechanism of Action Triple Agonist (GLP-1, GIP, and Glucagon Receptors)
    Primary Indication Advanced Chronic Weight Management & Metabolic Support
    Administration Route Subcutaneous Injection
    Storage Requirements Refrigerate at 2°C to 8°C; protect from direct sunlight
    Add to cart